The Addition Of Systemic High-Dose Methotrexate (Hd-Mtx) To Intrathecal Chemotherapy (It) For Central Nervous System (Cns) Prophylaxis Substantilly Reduces Cns Recurrence Rates In Patients With At-Risk Aggressive Lymphoma: A Historically Controlled Prospective Study.